Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07494396 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An AI-Based Erythema Measurement System for Psoriasis Lesions

StatusNot Yet Recruiting
PhaseNot specified
Started2026-11-01
View on ClinicalTrials.gov ↗

Amendment history

2026-08-03
minor
Study Status v1
Start date2026-04-20→2026-11-01
2026-03-20
minor
Original filing
Psoriasis is a common chronic inflammatory skin disease. Disease severity is commonly assessed using the Psoriasis Area and Severity Index (PASI), in which erythema is graded subjectively on a 0-4 scale. This visual assessment is prone to significant inter- and intra-rater variability. Although objective tools such as colorimeters provide accurate erythema measurement, their high cost limits routine clinical use. Smartphone imaging combined with artificial intelligence (AI) offers a practical alternative for objective assessment. However, variability in lighting conditions can affect image consistency. Incorporating a color calibration card enables accurate color normalization. This study aims to develop and validate an AI-based system for measuring erythema in psoriatic lesions using smartphone images with a color card, compared against a standard colorimeter to assess validity and reliability.
Trial Details
NCT Number NCT07494396
Lead Sponsor Khon Kaen University
Conditions Psoriasis
Enrollment 50 participants
Start Date 2026-11-01
Primary Completion 2027-04-20 (estimated)
Study Completion 2027-04-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-05